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Covalent modification of histones plays an im-
portant role in regulating chromatin dynamics
and transcription. Histone methylation was
thought to be an irreversible modification until
recently. Using a biochemical assay coupled
with chromatography, we have purified a JmjC
domain-containing protein, JHDM2A, which
specifically demethylates mono- and dimethyl-
H3K9. Similar to JHDM1, JHDM2A-mediated
histone demethylation requires cofactors Fe(II)
and a-ketoglutarate. Mutational studies indi-
cate that a JmjC domain and a zinc finger pres-
ent in JHDM2A are required for its enzymatic
activity. Overexpression of JHDM2A greatly re-
duced the H3K9 methylation level in vivo.
Knockdown of JHDM2A results in an increase
in the dimethyl-K9 levels at the promoter region
of a subset of genes concomitant with decrease
in their expression. Finally, JHDM2A exhibits
hormone-dependent recruitment to androgen-
receptor target genes, resulting in H3K9 de-
methylation and transcriptional activation.
Thus, our work identifies a histone demethylase
and links its function to hormone-dependent
transcriptional activation.
INTRODUCTION
Posttranslational histone modifications are involved in
a variety of cellular processes through regulating chroma-
tin dynamics (Strahl and Allis, 2000). It has become clear
that histonemethylation is an important part of this histone
modification repertoire and functions in heterochromatin
formation, X chromosome inactivation, and transcriptionalregulation (Margueron et al., 2005; Martin and Zhang,
2005). Histone methylation occurs on both arginine and
lysine residues and is catalyzed by three different protein
families which include: the protein arginine methyltrans-
ferase family, the SET domain-containing family, and the
Dot1 protein family (Lachner et al., 2003; Zhang and Rein-
berg, 2001). While histone arginine methylation generally
correlates with transcriptional activation, histone lysine
methylation can signal either activation or repression, de-
pending on the particular lysine residue which is methyl-
ated (Kouzarides, 2002; Zhang and Reinberg, 2001).
Even within the same lysine residue, the biological conse-
quence of methylation can differ depending on the meth-
ylation state (Santos-Rosa et al., 2002; Wang et al., 2003).
The steady-state level of histone modification is dic-
tated by the balance between addition and removal of
a given modification. While this notion is generally true
for acetylation, phosphorylation, and ubiquitylation, early
studies looking at the turnover of methyl groups in bulk
histones suggested that histone methylation was not re-
versible since the half-life of histones, and methyl lysine
residues within them, were similar (Byvoet, 1972). How-
ever, more recent studies indicate that histone methyla-
tion is dynamic in certain situations. For example, H3K9
methylation in some inducible inflammatory genes is
erased upon activation and restored upon transcriptional
repression (Saccani and Natoli, 2002). In addition, tri-
methyl-H3K27, which is associated with the inactive X
chromosome in the trophoblast stem (TS) cells, disap-
pears during TS cell differentiation (Plath et al., 2003; Silva
et al., 2003). The first example of an enzyme that was ca-
pable of turning over a methylated residue was the human
peptidylarginine deiminase 4 (PAD4/PADI4). PAD4/PADI4
convertsmonomethyl-arginine in histone H3 and H4 to cit-
rulline by demethylimination (Cuthbert et al., 2004; Wang
et al., 2004b). However, since PAD4/PADI4 catalyzed de-
methylimination does not generate arginine and given that
PAD4/PADI4 also acts on unmethylated arginine to gener-
ate citrulline, PAD4/PADI4 is not a strict demethylase.Cell 125, 483–495, May 5, 2006 ª2006 Elsevier Inc. 483
A recent study has uncovered a true histone lysine de-
methylase. Shi and colleagues demonstrated that LSD1/
BHC110 can specifically demethylate mono- and dimethyl
H3K4 in a FAD (flavin adenine dinucleotide)-dependent
oxidative reaction (Shi et al., 2004). Consistent with the
notion that H3K4 demethylation participates in transcrip-
tional repression, LSD1 was previously identified in sev-
eral histone deacetylase complexes (Hakimi et al., 2002;
Shi et al., 2003; You et al., 2001). Although there are poten-
tial LSD1 homologs in S. pombe, no apparent LSD1 ho-
mologs exist in S. cerevisiae even though at least three
distinct lysine residues on H3 can bemethylated in this or-
ganism. This observation, in combination with the fact that
oxidative demethylation catalyzed by the LSD1 family of
proteins is unable to demethylate trimethylated lysine res-
idues, raises the possibility that additional demethylases
that utilize a different enzymatic mechanisms exist.
In an effort to identify histone demethylases that differ
from the LSD1 family of proteins, we have developed an
in vitro histone demethylase assay based on the mecha-
nism used by the DNA repair demethylase AlkB (Falnes
et al., 2002; Trewick et al., 2002). Using this assay, coupled
with chromatography, we have purified and characterized
a family of H3K36 demethylases which we have called
JHDM1 (JmjC domain-containing histone demethylase 1;
Tsukada et al., 2006). In a parallel study, using G9a-meth-
ylated histone substrates, we have purified and character-
ized a second JmjC domain-containing histone demethy-
lase JHDM2A that specifically demethylates H3K9. We
demonstrate that the enzymatic activity of JHDM2A de-
pends on an intact JmjC domain and requires cofactors
Fe(II) and a-ketoglutarate (a-KG). Although JHDM2A is ca-
pable of demethylating mono- and dimethyl-H3K9 in vitro
and in vivo, it fails to demethylate trimethyl-H3K9. siRNA-
mediated knockdown of JHDM2A results in decreased
gene expression concomitant with increased promoter
H3K9methylation. Importantly, JHDM2A interacts directly
with androgen receptor (AR) and is recruited to AR target
genes in a hormone-dependent manner to mediate tran-
scription activation. Thus, our work identifies a novel his-
tone demethylase and links its function to hormone-
dependent transcriptional activation.
RESULTS
Identification of a Histone Demethylase Activity
in HeLa Cell Nuclear Extracts
Using a novel biochemical assay, we have recently purified
and characterized an H3K36-specific histone demethyl-
ase JHDM1A (Tsukada et al., 2006). We demonstrate
that JHDM1A-mediated histone demethylation utilizes
Fe(II) and a-KG as cofactors generating formaldehyde
and succinate and requires the evolutionarily conserved
JmjC domain for its activity (Tsukada et al., 2006). In that
study, we used SET2-methylated nucleosomal histone
substrates tomonitor histone demethylase activity. In par-
allel studies, we also used histone substrates methylated
by other histone methyltransferases, including the H3K9484 Cell 125, 483–495, May 5, 2006 ª2006 Elsevier Inc.methyltransferase G9a (Tachibana et al., 2002). When
the G9a-methylated histone substrates were subjected
to demethylation assays using the protein fractions de-
rived from HeLa nuclear extracts (NE) and nuclear pellet
(NP; Wang et al., 2001b), we detected a potential H3K9
demethylase activity in the nuclear extract-derived 0.3 M
P11 protein fraction (Figure 1A) . To ascertain whether
this activity is the result of a genuine demethylase, we ex-
amined its dependency on the required cofactors Fe(II)
and a-KG. Results shown in Figure 1B demonstrate that
release of formaldehyde not only requires the presence
of the protein fraction (Figure 1B, compare lanes 1 and
5), but also the cofactors Fe(II) and a-KG (Figure 1B, com-
pare lanes 2 and 3 with lane 1). Addition of ascorbate,
which is involved in regenerating Fe(II) from Fe(III), ap-
pears to stimulate formaldehyde production (Figure 1B,
compare lanes 1 and 4). These results indicate that a his-
tone demethylase activity is present in the nuclear extract-
derived 0.3 M P11 fraction and the candidate enzyme
likely uses the same oxidative demethylation mechanism
used by JHDM1A for histone demethylation (Tsukada
et al., 2006).
Purification and Identification of a Histone
Demethylase Activity
To identify the protein(s) responsible for this demethylase
activity, we monitored the enzymatic activity through five
chromatography columns (Figure 2A). After purification
of the 0.3 M P11 fraction through DEAE5PW and Phenyl
Sepharose columns, we determined that the native
mass of the enzymatic activity is about 300 kDa as as-
sessed by a Sephacyl S300 column (Figure 2B). Further
purification on a MonoS column allowed us to correlate
the enzymatic activity (Figure 2C, bottom panel) to a pro-
tein of about 150 kDa, marked by * (Figure 2C, top panel).
Because there is a dramatic difference in the enzymatic
activities between fractions 17 and 20 (Figure 2C), we con-
centrated these two fractions and compared their protein
composition by SDS-PAGE (Figure 2D). After recovering
protein bands unique to fraction 20, they were subjected
tomass spectrometry analysis which revealed the protein,
marked by *, to be a novel JmjC domain-containing pro-
tein named JMJD1A (jumonji domain-containing 1A) or
TSGA (testis-specific geneA;Hooget al., 1991; Figure 2D).
To verify that JMJD1A is responsible for the detected de-
methylase activity, an antibody against this protein was
generated and used to immunoprecipitate JMJD1A from
the MonoS column fractions 21–29. The immunoprecipi-
tated sample was divided for silver staining, Western
blot, and demethylase assays. Results shown in Figure 2E
demonstrate that the demethylase activity (bottom panel)
was completely depleted from the supernatant (S), which
correlates with depletion of the JMJD1A (middle panel).
Importantly, silver staining (top panel) revealed a single
protein corresponding to JMJD1A. Furthermore, Western
blot analysis of the MonoS column fractions demon-
strated a perfect correlation between JMJD1A and the
enzymatic activity (Figure 2C, bottom two panels). These
Figure 1. Identification of a Histone De-
methylase Activity in HeLa Cells
(A) Histone demethylase activity against G9a-
methylated histone substrates was analyzed
using P11 column fractions derived from HeLa
nuclear extract and nuclear pellet fractions.
The numbers above the panel represent the
molar concentrationofKCl in theelutionbuffers.
(B) The demethylase activity present in the nu-
clear extracts of the 0.3MP11 fractionwere de-
pendent on Fe(II) and a-KG.results collectively suggest that JMJD1A is responsible for
the detected demethylase activity. Given that the native
size of JMJD1A is about 300 kDa (Figure 2B), it is likely
that JMJD1A functions as a homodimer. Because histone
demethylase activity is the first identified activity of this
protein and that it is the second JmjC domain-containing
histone demethylase that we have identified, we have
renamed the protein JHDM2A (JmjC domain-containing
histone demethylase 2A) to reflect its newly identified
function. Accordingly, we have named the other two
JHDM2A-related human proteins JHDM2B and JHDM2C,
respectively (Figure 3C).
JHDM2A was first identified in a testis cDNA library
(Hoog et al., 1991). In situ hybridization studies indicated
that JHDM2A is highly expressed in male germ cells,
and its steady-state transcript levels are the highest during
the meiotic and the postmeiotic stages of germ cell devel-
opment (Hoog et al., 1991). Domain structure analysis us-
ing theSMARTprogram (http://smart.embl-heidelberg.de)
revealed the presence of a JmjC domain and a zinc finger
(Figure 3A). Given our recent demonstration that JmjC
domain is a signature motif for histone demethylases
(Tsukada et al., 2006), the presence of a JmjC domain in
JHDM2A strongly suggests that JHDM2A is responsible
for the detected histone demethylase activity. To directly
demonstrate the demethylase activity of JHDM2A, we
transfected COS-7 cells with a FLAG-tagged mammalian
expression vector. After immunoprecipitation with the
anti-FLAG conjugated beads, the immunoprecipitates
were split for Western and enzymatic activity assays. Re-
sults shown in Figure 3B (lane 1) revealed a robust histone
demethylase activity dependent on the FLAG-JHDM2A
protein.
To evaluate the importance of the JmjC and the zinc fig-
ure domains for the enzymatic activity of JHDM2A, we
generated four expression constructs with deletions of
the N terminus, zinc finger, N terminus plus zinc finger,
and JmjC domain, respectively (Figure 3A). After transfec-tion and immunoprecipitation, these mutant proteins were
subjected to Western blotting and demethylase activity
assays. Results shown in Figure 3B indicate that both
the zinc finger and the JmjC domain are critical for enzy-
matic activity (Figure 3B, compare lane 1 with lanes 4–
6). To further demonstrate the importance of the JmjC
domain for enzymatic activity, we generated a single
amino acid substitution, H1120Y, in the JmjC domain.
We choose to mutate amino acid H1120 because this
histidine is highly conserved in the JmjC domain of
JHDM2A-related proteins (Figure 3D), and the corre-
sponding histidine in FIH (factor-inhibiting HIF [hypoxia-
inducible factor]), a known Fe(II) dependent oxygenase,
was found to directly bind to Fe(II) (Elkins et al., 2003).
Fe(II) dependency of the histone demethylase activity
(Figure 1B) predicts that the H1120Y mutation will disrupt
Fe(II) binding and thus impair the enzymatic activity of
JHDM2A. Results shown in Figure 3B confirmed this pre-
diction (Figure 3B, compare lanes 1 and 2). The impor-
tance of the JmjC and zinc finger for the demethylase ac-
tivity was also verified in vivo (Figure 5 and see Figure S1 in
the Supplemental Data available with this article online).
Therefore, we conclude that JHDM2A is a novel histone
demethylase and that its JmjC and zinc inger domains
are both critical for its enzymatic activity.
JHDM2A Demethylates H3 Mono- and Dimethyl-K9
In Vitro
To further characterize JHDM2A, we generated a baculo-
virus expressing a FLAG-tagged JHDM2A and purified the
protein from infected Sf9 cells by affinity chromatography.
After evaluating the purity and quantifying the FLAG-
JHDM2A protein (Figure 4A), we analyzed and compared
its enzymatic activity with that of the native JHDM2A pro-
tein. Results shown in Figure 4B demonstrated that re-
combinant FLAG-JHDM2A and native JHDM2A have sim-
ilar activity when equal amounts of proteins are compared
(Figure 4B, compare lane 1 with lanes 4 and 5). To analyzeCell 125, 483–495, May 5, 2006 ª2006 Elsevier Inc. 485
Figure 2. Purification and Identification of a Histone Demethylase Activity
(A) Schematic representation of the steps used to purify the demethylase activity. Numbers represent the salt concentrations (mM) at which the his-
tone demethylase activity elutes from the column.
(B) Histone demethylase activity of the protein fractions derived from a Sephacyl S300 gel-filtration column. The elution profile of the protein markers
is indicated on top of the panel.
(C) A silver-stained protein gel (top panel), Western blot (middle panel), and histone demethylase activities (bottom panel) of the protein fractions de-
rived from a MonoS column. A candidate protein that cofractionated with the demethylase activity is indicated by *. The positions of the protein size
markers on SDS-PAGE are indicated to the left of the panel.
(D) A silver-stained protein gel comparing the composition of the histone demethylase positive fraction 20 with the adjacent histone demethylase
negative fraction 17. The candidate protein was identified by mass spectrometry. A total of 63 peptides covering 53% of the JMJD1A
(NP_060903) were identified. Representative peptides identified frommass spectrometry are listed. The numbers correspond to the amino acid num-
bers of the JMJD1A protein.
(E) Silver-staining (top panel), Western blot (middle panel), and histone demethylase assays (bottom panel) of the immunoprecipitated sample using
a JMJD1A antibody. In, S, and B represent input, supernatant, and bound, respectively. The input sample was derived by pooling fractions 21–29 of
the MonoS column.the site specificity of JHDM2A, histone substrates radiola-
beled at all known methyl lysine sites in histones H3 (K4,
K9, K27, K36, K79) and H4 (K20) were subjected to a de-486 Cell 125, 483–495, May 5, 2006 ª2006 Elsevier Inc.methylation assay containing purified recombinant FLAG-
JHDM2A. Of the six substrates, only H3K9 methylated by
G9a was a substrate for JHDM2A (Figure 4C). In addition
Figure 3. JmjC and Zinc Finger Domains of JHDM2A Are Both Required for Histone Demethylase Activity
(A) Schematic representation of the wild-type and mutant JHDM2A proteins with their activities (right). + represents active and represents inactive.
(B) Wild-type and mutant FLAG-JHDM1A proteins were expressed in COS-7 cells and immunoprecipitated using a FLAG antibody. The immunopre-
cipitates were divided for Western blotting (top panel) and demethylase assays (bottom panel).
(C) Diagrammatic representation of the JHDM2 family of proteins from different organisms. Three related proteins were identified in human and
mouse, but only one homolog was found in Drosophila and Xenopus. The JmjC and zinc finger domains present in this family of proteins are shown
based on analysis using the SMART program.
(D) Alignment of the JmjC domain of the JHDM2 family members with that of FIH1 using the PAPIA system (www.cbrc.jp/papia/papia.html). The ac-
cession number for each of the proteins in the alignment is listed. The numbers represent the amino acid numbers of each protein. The amino acids in
FIH1 that are involved in Fe(II) and a-KG binding are indicated by * and #, respectively. Conserved sequences are highlighted with black background.to H3K9, previous studies indicated that G9a can also
methylate H3K27 in vitro (Tachibana et al., 2002). To verify
that JHDM2A specifically demethylates H3K9, but not
H3K27, we generated radiolabeled substrate histone H3
that contains either a K9R or a K27R mutation using theG9a HMT. In parallel, we also included radiolabeled
wild-type recombinant H3 and HeLa core histones in the
assay. Results shown in Figure 4D demonstrate that
JHDM2A is not able to demethylate H3 when K9 is mu-
tated (Figure 4D, compare lanes 5 and 6), while the K27Cell 125, 483–495, May 5, 2006 ª2006 Elsevier Inc. 487
Figure 4. Characterization of the Site and
Methylation State Specificity of JHDM2A
(A) A Coomassie-stained protein gel of the pu-
rified FLAG-JHDM2A protein expressed in Sf9
cells compared with BSA. The lower band in
lane 3 is a degradation product as verified by
Western.
(B) Comparable histone demethylase activity of
recombinant JHDM2A made in Sf9 cells and
the native JHDM2A purified from HeLa cells.
Fixed amounts of native JHDM2A were com-
pared with varying amounts of recombinant
JHDM2A, quantified by Western blot analysis
using JHDM2A antibody (top panel) and his-
tone demethylase activities (bottom panel).
(C) Histone demethylase activity of FLAG-
JHDM2A toward equal counts of various meth-
ylated histone substrates. Similar results were
obtained when equal amounts of substrates
in micrograms were used. The histone methyl-
transferases (HMTs) that were used in generat-
ing the various substrates are indicated on top
of the panel.
(D) FLAG-JHDM2A demethylates G9a-methyl-
ated H3K9, but not H3K27. Native histones pu-
rified from HeLa cells and recombinant histone
H3, wild-type, or mutant (K9R, K27R), purified
from E. coli, were methylated by G9a and sub-
jected to demethylase assays in the presence
(+) or absence () of FLAG-JHDM2A.
(E and F) Mass spectrometry analysis of de-
methylation of a dimethyl-K9 (E) or a trimethyl-
K9 (F) peptide (acetyl-ARTKQTARmeKSTGGKA
PRK-biotin) by FLAG-JHDM2A. The enzyme/
substrate molar ratio of the reaction is 1:40.
Numbers represent the masses of the substrate
and product peptides.mutation does not affect the activity of JHDM2A (Fig-
ure 4D, compare lanes 7 and 8). Thus, we conclude that
JHDM2A is an H3K9-specific demethylase.
Lysine residues exist in three methylation states (mono-,
di-, and trimethylation). To determine whether JHDM2A
preferentially demethylates a particular methylation state,
we performed a demethylation assay using H3K9-methyl-
ated peptide substrates and analyzed demethylation
products by mass spectrometry. Results shown in Fig-
ure 4E demonstrate that demethylation of a dimethyl-K9
peptide depends on the presence of JHDM2A and gener-
ated products with masses that correlate with both mono-
methyl and unmethylated forms of the peptide, indicating
that bothmono- and dimethyl-K9 can serve as substrates.
In contrast, no demethylation was detected when a tri-
methyl-K9 peptide that has the same sequence was sub-
jected to parallel analysis (Figure 4F). Based on the above
results, we conclude that JHDM2A selectively demethyl-
ates H3-mono- and dimethyl-K9.
JHDM2A Demethylates H3 Mono- and Dimethyl-K9
In Vivo
Having demonstrated demethylase activity for JHDM2A
in vitro, we sought to test its activity in vivo. To this end,488 Cell 125, 483–495, May 5, 2006 ª2006 Elsevier Inc.we investigated the effect of overexpression JHDM2A
on the H3K9 methylation levels by immunostaining. We
find that overexpression of JHDM2A greatly reduced the
dimethyl-H3K9 level (Figure 5A). This effect is not simply
a result of inaccessibility of modification-specific antibody
due to the presence of FLAG-JHDM2A because overex-
pression of an enzymatically defective mutant did not af-
fect dimethyl-H3K9 levels (Figure 5B). In addition, overex-
pression of JHDM2A does not alter the expression level of
several knownH3K9methyltransferases (Figure S2). A de-
crease in the level of monomethyl-H3K9 was also ob-
served in cells that overexpress JHDM2A (Figure 5C).
However, no effect was observed on the levels of tri-
methyl-H3K9 (Figures 5D and S3) or dimethyl-H3K27
(Figure 5E). These results indicate that JHDM2A demethy-
lates mono- and dimethyl-H3K9, with a preference for di-
methyl-H3K9, in vivo.
JHDM2A Knockdown Leads to Decreased
Transcription Concomitant with Increased
Promoter H3K9 Dimethylation
Previous studies have linked H3K9 methylation to tran-
scriptional repression and heterochromatin formation
(Martin and Zhang, 2005). Therefore, a H3K9 demethylase
Figure 5. JHDM2A Demethylates Mono-
and Dimethyl-H3-K9 In Vivo
COS-7 cells were transfectedwith wild-type (A,
C, D, and E) or mutant (B) FLAG-JHDM2A.
Cells were costained with FLAG antibody and
different methyl-H3K9 or dimethyl-H3K27 anti-
bodies as indicated in the figure. Arrows point
to the transfected cells.could potentially antagonize gene silencing. To test this
possibility, we generated stable Jhdm2a knockdown cells
using a vector-mediated RNAi approach (Okada et al.,
2005). We choose to perform knockdown in F9 cells be-
cause this cell line exhibits the highest Jhdm2a expression
in the three cell lines that we have analyzed (Figure 6A).
Quantitative PCR (Figure 6B, left panel) and Western blot
analysis (Figure 6B, right panel) confirmed that the knock-
down efficiency is about 80% at the RNA level and about
70% at the protein level. Compared to the parental F9
cells, no apparent morphological changes were observed
in the knockdown cells (data not shown), indicating either
that Jhdm2a does not play a critical role in maintaining the
undifferentiated state of F9 cells or that the highly related
Jhdm2b which is also a H3K9 demethylase expressed in
F9 cells (data not shown) may compensate for Jhdm2a
function. Although no apparent cell differentiation was
observed in response to Jhdm2a knockdown, we havenevertheless analyzed potential changes in expression
levels of several differentiation mark genes. The genes
that we analyzed include the pluripotency marks (Nanog,
Oct4, and Sox2) and differentiation marks (Lamb1,
Hoxa1, Hoxb1, and Stra6). Results shown in Figure 6C in-
dicate that, in response to Jhdm2a knockdown, Nanog
and Oct4 are down regulated about 20%, while the differ-
entiation marks Lamb1, Hoxb1, and Stra6 are downregu-
lated about 40%–60%. These results are consistent with
the notion that Jhdm2a functions as a H3K9 demethylase
to positively regulate transcription. In contrast, Hoxa1 ex-
pression is upregulated by Jhdm2a knockdown perhaps
due to indirect effects (see below).
To investigate whether the observed transcriptional ef-
fects due to Jhdm2a knockdown represent a direct effect,
we analyzed binding of the JHDM2A protein to the LamB1
and Stra6 promoters by ChIP assay. As a control, we also
analyzed its binding to the Hoxa1 gene promoter. ResultsCell 125, 483–495, May 5, 2006 ª2006 Elsevier Inc. 489
Figure 6. Knockdown of Jhdm2a in F9
Cells Results in Decreased Transcription
Concomitant with Increased Promoter
H3K9 Dimethylation
(A) Relative expression level of Jhdm2a in
NIH3T3, P19, and F9 cells analyzed by quanti-
tative RT-PCR. Data represent average of three
independent experiments with error bars.
(B) Characterization of a Jhdm2a knockdown
F9 cell line. Quantitative RT-PCR (left panel)
and Western blot analysis (right panel) indi-
cates that about 80% knockdown of Jhdm2a
at the RNA level and 70% knockdown at the
protein level were achieved. Data represent av-
erage of three independent experiments with
error bars.
(C) Quantitative RT-PCR analysis of changes in
RNA level of several pluripotency and differen-
tiation marker genes in response to Jhdm2a
knockdown. The changes are expressed as
the ratio of the expression level in knockdown
cells to that of the wild-type control. Data rep-
resent average of three independent experi-
ments with error bars.
(D) Q-PCR results of ChIPed DNA in control
(open bars) and Jhdm2a knockdown (filled
bars) cells. The gene promoters analyzed and
the antibodies used for ChIP are indicated. All
Q-PCR have been repeated three times. The
average with standard deviation is presented.
Data represent average of three independent
experiments with error bars.shown in Figure 6D indicate that JHDM2A binds to the
LamB1 and Stra6 promoters, but not the Hoxa1 promoter
(Figure 6D, compare columns 1 and 2 with 3). Knockdown
of Jhdm2a significantly decreased JHDM2A binding, indi-
cating the detected ChIP signals are specific (Figure 6D,
columns 1 and 2). Consistent with the observation that
JHDM2A functions as a dimethyl-K9 demethylase, knock-
down Jhdm2a increased the dimethyl-K9 levels at the
LamB1 and Stra6 promoters but had little effect on the
Hoxa1 promoter (Figure 6D, columns 4–6). Consistent
with the fact that Jhdm2a is a dimethyl-K9-specific deme-
thylase, knockdown Jhdm2a did not cause a significant
alteration in the trimethyl-K9 levels on any of the three
promoters analyzed (Figure 6D, columns 7–9). Based on
these results, we conclude that JHDM2A is targeted to
a subset of genes to demethylate dimethyl-K9 and posi-
tively regulate expression of these genes.
JHDM2A-MediatedH3K9DemethylationContributes
to Hormone-Dependent AR Activation
JHDM2A has two closely related homologs, JHDM2B and
JHDM2C (Figure 3C). Interestingly, JHDM2C was first
identified in a yeast two-hybrid screen as a thyroid hor-
mone receptor (TR)-interacting protein named TRIP8
(Lee et al., 1995). In addition, JHDM2A contains an
885LXXLL889 sequence, which is a signature motif involved490 Cell 125, 483–495, May 5, 2006 ª2006 Elsevier Inc.in nuclear hormone-receptor interaction (Heery et al.,
1997). These observations prompted us to test for poten-
tial involvement of JHDM2A in transcriptional regulation
by nuclear receptors.While we failed to detect a hormone-
dependent interaction with TR by both in vitro pull-down
and coimmunoprecipitation assays (data not shown), we
found that JHDM2A interacted with androgen receptor
(AR) in a ligand-dependent manner (Figure 7A). To investi-
gate the in vivo relevance of this in vitro interaction, we
asked whether JHDM2A is recruited to known AR target
genes in a hormone-dependent manner. Thus, we per-
formed ChIP assays on two well-characterized AR target
genes, PSA and NKX3.1, in LNCaP cells in the presence
or absence of hormone. Results shown in Figure 7B dem-
onstrated a strong binding of the AR to the PSA enhancer
upon R1881 treatment (Figure 7B, third panel, compare
lanes 1 and 2). Similarly, strong hormone-dependent bind-
ing of the AR to a region containing a functional ARE (AR
enhancer) located 3 kb upstream of the NKX3.1 tran-
scriptional start site was also detected (Figure 7B, third
panel, compare lanes 3 and 4). Consistent with hor-
mone-induced transcriptional activation (data not shown),
an increase in histone acetylation was detected in both
cases (Figure 7B, fourth panel). Importantly, R1881 treat-
ment also led to increased association of JHDM2A with
AR target genes (Figure 7B, fifth panel), concomitant
Figure 7. JHDM2AFunctions asaCoacti-
vator for AR and Is Required for Hor-
mone-Induced H3K9 Demethylation
(A) JHDM2A interacts with AR in a hormone-
dependent manner in vitro. Recombinant
JHDM2A was mixed with in vitro translated
35S-labeled AR in the absence or presence of
R1881 (100 nM). After immunoprecipitation
with anti-JHDM2A antibody, AR was detected
by autoradiography.
(B) Hormone-dependent recruitment of
JHDM2A to the PSA and NKX3.1 enhancers
in vivo. LNCaP cells were cultured in char-
coal-stripped serum medium for 3 days and
then treated without or with R1881 (50 nM) for
1 hr before processing for ChIP assays.
(C) Knockdown of JHDM2A and LSD1 in
LNCaP cells by siRNA. LNCaP cells were trans-
fected with a scramble (siCon), siJHDM2A, or
siLSD1 as indicated. Tubulin serves as a load-
ing control.
(D) Quantitative RT-PCR analysis showing the
effect of JHDM2A or LSD1 knockdown on
R1881-dependent activation of three AR target
genes. The cells were treated as in (B) except
the cells were collected for RNA isolation 8 hr
after the R1881 treatment.
(E) Knockdown of JHDM2A impaired hormone-
induced H3K9 demethylation. The LNCaP cells
were treated with siJHDM2A or siCon for 3
days and then 50 nMR1881 for 1 hr before pro-
cessed for ChIP assays using antibodies as
indicated.with decreases in the level of dimethyl- and trimethyl-
H3K9 (Figure 7B, sixth and seventh panels). In contrast
to JHDM2A, which binds to PSA and NKX3.1 genes in
a hormone-dependent manner, association of LSD1 with
these two genes was not affected by hormone treatment
(Figure 7B, last panel), consistent with a previous report
(Metzger et al., 2005).
To directly test and compare the role of JHDM2A and
LSD1 in hormone-dependent transcriptional activation,
we used siRNA to knockdown JHDM2A and LSD1 in
LNCaP cells (Figure 7C). We then evaluated the effects
of JHDM2A or LSD1 knockdown on the hormone-induced
activation of three AR target genes, PSA, NKX3.1, and
TMPRSS22, by quantitative RT-PCR. Results shown in
Figure 7D demonstrate that while treatment with R1881
for 8 hr robustly activated transcription from all three AR
target genes, knockdown of JHDM2A led to significant
reduction in hormone response. Although knockdown of
LSD1 also led to reduced hormone response, the effect
is not as significant in comparison with knockdown of
JHDM2A. Thus, we conclude that JHDM2A is critically im-
portant for optimal hormone-dependent transcriptional
activation by AR.To evaluate whether JHDM2A is important for the hor-
mone-induced H3K9 demethylation observed above (Fig-
ure 7B), we performed JHDM2A knockdown in LNCaP
cells followed by treatment with R1881 for 1 hr before
ChIP analysis. Results shown in Figure 7E demonstrate
that the hormone-induced recruitment of JHDM2A to the
PSA enhancer and NKX3.1 gene was largely abrogated
upon siJHDM2A treatment (Figure 7E, second panel,
compare lane 3 with lanes 2 and 4; compare lane 7 with
lanes 6 and 8). Importantly, knockdown of JHDM2A signif-
icantly impaired the hormone-induced reduction of di-
methyl-H3K9 at the PSA enhancer (Figure 7E, fourth
panel, compare lanes 2 and 3). Although to a lesser extent,
knockdown of JHDM2A also affected the hormone-
induced reduction of dimethyl-H3K9 at NKX3.1 (Figure 7E,
fourth panel, compare lanes 6 and 7). These results indi-
cate that JHDM2A is required for efficient demethylation
of repressive dimethyl-H3K9 at AR target genes. Interest-
ingly, although JHDM2A has no activity toward trimethyl-
H3K9 (Figures 4F, 5D, 6D, and S3C), knockdown of
JHDM2A also affected hormone-induced reduction of
trimethyl-H3K9 for both PSA enhancer and NKX3.1
(Figure 7E, last panel). Whether the observed effects onCell 125, 483–495, May 5, 2006 ª2006 Elsevier Inc. 491
trimethyl-H3K9 are direct or indirect remains to be deter-
mined. It is interesting to note that knockdown of JHDM2A
also appears to reduce the hormone-induced H3 acetyla-
tion levels (Figure 7E, third panel, compare lanes 2 and 3, 6
and 7). One explanation for this observation is that H3K9
demethylation is a prerequisite for H3K9 acetylation. On
the other hand, knockdown of JHDM2A did not affect
hormone-induced binding of AR to both target genes
(Figure 7E, first panel), suggesting that JHDM2A contrib-
utes to AR-mediated transcription activation subsequent
to its binding to target genes.
Previous studies indicate that LSD1 is also capable of
catalyzing dimethyl-H3K9 demethylation when it associ-
ates with AR (Metzger et al., 2005). To determine whether
LSD1 is required for hormone-dependent association of
JHDM2A with AR target genes, we analyzed occupancy
of JHDM2A and dimethyl-H3K9 levels of the PSA en-
hancer with or without LSD1 knockdown. Results shown
in Figure S4 demonstrate that knockdown of LSD1 af-
fected neither the binding of AR to the PSA enhancer
nor the hormone-induced recruitment of JHDM2A. How-
ever, knockdown of LSD1 did partially impair the hor-
mone-induced reduction of dimethyl-H3K9. This result
and the results shown in Figure 7 collectively indicate
that both JHDM2A and LSD1 contribute to hormone-
induced demethylation of dimethyl-H3K9 of the PSA en-
hancer.
DISCUSSION
Using a histone demethylase assay (Tsukada et al., 2006),
we purified and characterized a new H3K9 demethylase,
JHDM2A, that specifically targets mono- and dimethyl
H3K9 for demethylation. Consistent with the notion that
H3K9methylation is involved in transcriptional repression,
JHDM2A-mediated H3K9 demethylation plays an impor-
tant role in hormone-dependent AR activation.
Multiple Mechanisms Are Employed to Remove
Methyl Groups on Histones
Histonemethylationwasoriginally thought to be a ‘‘perma-
nent’’ modification. Before an enzyme capable of remov-
ing methyl groups was identified, at least two models
were proposed to explain the turnover of methyl groups
on histone molecules. The first model involved histone
tail clipping (Allis et al., 1980), while the second model in-
volved replacement of methylated histone with a variant
histone (Ahmad and Henikoff, 2002). Recent studies indi-
cate that enzyme-catalyzed turnover of methyl groups on
histone is more prominent than was originally thought. For
example, PAD4/PADI4 can convert monomethyl arginines
on histone H3 and H4 to citrulline by demethylimination
(Cuthbert et al., 2004; Wang et al., 2004b). LSD1, a mem-
ber of the amine oxidase family, has been recently shown
to catalyze demethylation of mono- and dimethyl-H3K4
through a FAD-dependent oxidative reaction (Shi et al.,
2004). Using an unbiased biochemical assay (Tsukada
et al., 2006), we have successfully purified and character-492 Cell 125, 483–495, May 5, 2006 ª2006 Elsevier Inc.ized two distinct histone demethylases, JHDM1A and
JHDM2A, that target different lysine residues of histone
H3 for demethylation. Interestingly, both demethylases
contain an evolutionarily conserved JmjC domain and re-
quire Fe(II) and a-KG as cofactors. Thus, at least two fam-
ilies of proteins, the amine oxidase family and the JmjC do-
main-containing family, can convertmethyl lysine to lysine.
The chemical nature of the amine oxidation reaction
prevents the LSD1 family of demethylases from catalyzing
the removal of trimethyl lysine, since this reaction requires
a protonated nitrogen (Bannister et al., 2002). However,
the JmjC domain-containing proteins, which use an oxida-
tive hydroxylation mechanism for histone demethylation
(Trewick et al., 2005), do not have such a limitation. Sur-
prisingly, JHDM1A and JHDM2A can only demethylate
mono- and dimethyl lysine. The fact that both JmjC family
of histone demethylases that we identified (JHDM1 and
JHDM2) act only on mono- and dimethyl lysine, does not
mean that the trimethyl state is irreversible. Instead, we
believe our observation is simply a reflection of the nature
of the substrates that we have used in the purification of
these two enzymes. In vitro, both Set2 and G9a predom-
inantly methylate lysine residues to dimethyl state. Con-
sistent with this rationale, we have successfully identified
JHDM3, a novel histone demethylase capable of demeth-
ylating trimethyl-H3K9 and trimethyl-H3K36 (R. Klose,
K.Y., and Y.Z., unpublished data). Therefore, JmjC do-
main-containing proteins are capable of demethylating
all the three methyl lysine states.
Both JHDM1A and JHDM2A exhibit striking substrate
specificity. They not only selectively demethylate a single
lysine residue but also demethylate particular lysine
states. We speculate that the site specificity is likely deter-
mined by interactions between the amino acids adjacent
to the lysine residues on histones and the catalytic domain
of the enzyme. The methylation state specificity may be
determined by the size of the catalytic site, analogous to
the situation observed for SET domain histone methyl-
transferases. If the catalytic site of these histone demethyl-
ases is spatially constrained, it is possible that they are
unable to accommodate a trimethyl lysine residue. Struc-
tural studies are required to clarify these predictions. The
striking specificity of these histone demethylases sug-
gests a large number of demethylases are required to sat-
isfy the diverse range of enzymatic requirements and
counteract histone methylation. The LSD1 family has
about ten related proteins and only a few are potential his-
tone demethylases (Kubicek and Jenuwein, 2004). Al-
though more than 30 JmjC domain-containing proteins
exist in mammals, the amino acids predicted to bind co-
factors are not conserved in many of these proteins
(K.Y. and Y.Z., unpublished data). In addition, some of
the predicted demethylases are likely to target none
histone proteins as substrates. Furthermore, enzymes
capable of directly removing methyl groups from methyl-
arginine remain to be identified. Therefore, histone de-
methylases that do not belong to the LSD1 or the JmjC
families are likely to be discovered.
JHDM2A Functions as a Coactivator for AR
JHDM2A was initially cloned as a male germ cell-specific
gene from rat (Hoog et al., 1991). In situ hybridization stud-
ies indicate that JHDM2A is mainly expressed in male
germ cells and the steady-state transcript levels are high-
est during the meiotic and postmeiotic stages of germ cell
development (Hoog et al., 1991). This indicates that
JHDM2A may have a role in male germ cell development.
Interestingly, rapid turnover of H3K9methylation has been
observed during germ cell development (Morgan et al.,
2005; Seki et al., 2005). Whether JHDM2A is responsible
for this rapid turnover remains to be determined. Consis-
tent with the observation that JHDM2A is highly expressed
in male germ cells, we found that JHDM2A is highly ex-
pressed in the F9 embryonic carcinoma cells derived
from testis. ChIP analysis indicates that JHDM2A is bound
to promoters of several differentiation-associated genes,
where it maintains low levels of expression in the undiffer-
entiated state. These genes include LamininB1 and Stra6
(Figure 6). LamininB1 is an important component of the
extracellular matrix, but recent studies indicate that it
also facilitates germ cell movement (Siu andCheng, 2004).
Stra6 is a membrane protein expressed in the Sertoli cells
of the testis and is regulated in a spermatogenic cycle-de-
pendent manner (Bouillet et al., 1997). Thus, involvement
of JHDM2A in LamininB1 and Stra6 expression points to
a function for JHDM2A in male germ cell development.
In addition to the constitutive binding and function
in maintaining gene expression observed in F9 cells,
JHDM2A also responds to hormone treatment during up-
regulation of AR target genes. Our finding that JHDM2A in-
teractswith liganded AR in vitro and is recruited to the PSA
and NKX3.1 enhancers in a ligand-dependent manner in
LNCaP cells suggests JHDM2A likely functions as a tran-
scriptional coactivator for AR (Figure 7B). Indeed, using
a siRNA-mediated knockdown approach, we confirmed
that JHDM2A is required for optimal transcriptional activa-
tion of all threeAR target geneswe have tested (Figure 7D).
Consistent with a previous report (Metzger et al., 2005),
we confirmed that knockdown of LSD1 affects transcrip-
tional activation by AR. Importantly, knockdown of
JHDM2A or LSD1 impairs hormone-induced reduction of
dimethyl-H3K9 (Figures 7E and S4), thus providing strong
evidence that JHDM2A and LSD1 both participate in the
demethylation of the PSA enhancer in response to hor-
mone treatment. Since knockdown of JHDM2A or LSD1
does not affect AR binding, our data suggest that de-
methylation of H3K9 is required for a subsequent step(s)
in hormone-dependent transcriptional activation. Because
JHDM2A is unable to remove trimethyl-K9, we suspect
that the effect of JHDM2A knockdown on trimethyl-
H3K9 could be indirect. Although unlikely, we cannot
rule out the possibility that JHDM2A may be able to de-
methylate trimethyl-H3K9 once targeted to chromatin by
AR. In this regard, LSD1 was shown to convert from
a H3K4 demethylase to a H3K9 demethylase when asso-
ciatedwith AR (Metzger et al., 2005). The demonstration of
the involvement of JHDM2A in transcriptional activationby AR suggests that JHDM2A likely has a widespread
role in transcriptional regulation.
EXPERIMENTAL PROCEDURES
Histone Demethylase Assay, Protein Identification,
and Mass Spectrometry
The histone demethylase assay was performed essentially as previ-
ously described (Tsukada et al., 2006). A detailed description can be
found in Supplemental Experimental Procedures. For protein identifi-
cation, the candidate polypeptide was digested with trypsin, and the
protein was identified as previously described (Wang et al., 2004a).
For peptide substrate analysis, an aliquot (1 ml) of the demethylation re-
action mixture was diluted 100-fold with 0.1% formic acid and loaded
onto a 2 ml bed volume of Poros 50 R2 (PerSeptive Biosystems) re-
versed-phase beads packed into an Eppendorf gel-loading tip. The
peptides were eluted with 5 ml of 30% acetonitrile/0.1% formic acid.
A fraction (0.5 ml) of this peptide pool was analyzed bymatrix-assisted
laser-desorption/ionization (MALDI) time-of-flight (TOF) mass spec-
trometry (MS), using a BRUKER UltraFlex TOF/TOF instrument (Bruker
Daltonics) as described (Erdjument-Bromage et al., 1998).
Constructs and Antibodies
Plasmids encoding GST-SET7, GST-SET8, GST-hDOT1L (1–416), and
components of the EZH2 complex have been previously described
(Cao and Zhang, 2004; Min et al., 2003; Wang et al., 2001a, 2001b).
Plasmids encoding GST-G9a (621–1000), and CBP-Set2-FLAG (S.
pombe) were kindly provided by Drs. Shinkai, and Strahl, respectively.
A plasmid encoding hJHDM2A was constructed by PCR amplification
from a human KIAA clone (KIAA 0742) and was inserted into XhoI sites
of an N-terminal FLAG-tagged pcDNA3 vector or an N-terminal FLAG-
tagged pFASTBAC vector. pcDNA3-FLAG-JHDM2A (H1120Y) and de-
letion mutants (489–1321 aa, 766–1321 aa, 1–1009 aa, and D623–717)
were generated by PCR. All the constructs generated through PCR
were verified by sequencing. RNAi constructs were made by synthe-
sizing oligonucleotides encoding 19 bp short-hairpin RNA that target
mJhdm2a (RNAi1, 50-GTACAAGAAGCAGTAATAA-30; RNAi2, 50-
AGGTGTCACTAGCCTTAAT-30) and cloned into pMSCVneo retrovirus
vector (Clonetech) under the regulation of H1 RNA promoter as de-
scribed previously (Okada et al., 2005).
The sources of the antibodies used are as follows: H3 trimethyl-K4
(Abcam 8580), H3 monomethyl-K9 (Abcam 9045), H3 dimethyl-K9
(Upstate 07-411), and H3 dimethyl-K27 (Upstate 07-452). H3 tri-
methyl-K9 antibody has been previously described (Plath et al., 2003).
The AR (N-20) antibody and acH3 antibody were purchased from
Santa Cruz and Upstate, respectively. The antibody against FLAG
and secondary antibodies for immunofluorescence were purchased
fromSigma and Jackson ImmunoResearch Laboratories, respectively.
Antibodies against hJHDM2A were generated in rabbits using the first
495 amino acids of the protein as antigen.
Immunostaining
COS-7 and NIH3T3 cells were plated onto glass coverslips in a 12-well
plate and cultured for 1 day. Cells were transiently transfected with
plasmids by FuGene6. Two days after transfection, cells were washed
with PBS and fixed in 4% paraformaldehyde for 10 min. The cells were
then washed three times with cold PBS and permeabilized for 5 min
with cold PBS containing 0.2% Triton X-100. Permeabilized cells
were then washed three times with blocking buffer (1% bovine serum
albumin in PBS) and blocked for 30 min before incubation with primary
antibodies for 1 hr in a humidified chamber. After three consecutive
5 min washes with PBS, cells were incubated with secondary anti-
bodies for 1 hr before being washed with PBS and stained with 4,6-
diamidino-2-phenylindole dihydrochloride (DAPI) in PBS. Cells were
washed again twice with PBS and then mounted in fluorescentCell 125, 483–495, May 5, 2006 ª2006 Elsevier Inc. 493
mounting medium (Dako) before viewing under a Zeiss immunofluo-
rescence microscope.
Generation of a Stable JHDM2A Knockdown Cell Line
F9 cells were cultured in DMEM media supplied with 10% FBS on
0.1% gelatin-coated plates. The MSCVneo-JHDM2A siRNA vector
was cotransfected with pGag-pol and pVSVG into 293T cells by cal-
cium-phosphate mediated transfection. At 48 to 72 hr posttransfec-
tion, the supernatants were collected and were used for transduction
of F9 cells by spinoculation. Stable transfectants were selected in
the presence of 500 mg/ml G418 (Gibco). Cells derived from these
transfectants were used for Western blotting, real-time PCR, and
ChIP analysis.
AR-JHDM2A Interaction
The in vitro translated 35S-methionine labeled AR (10 ml) was mixed
with 3 ml (300 ng) of purified recombinant JHDM2A in binding buffer
(20 mM HEPES [pH7.6], 50 mM KCl, 1 mM DTT, 0.5 mM PMSF, and
10% glycerol) in the presence or absence of 100 nM R1881 in a
100 ml reaction and rotated in the cold room for 2 hr. Protein A agarose
beads and anti-JHDM2A antibody (10 ml) were then added and incu-
bated for 1 hr. After extensive washing with the binding buffer, the
AR was resolved by a 10% SDS-PAGE and visualized by autoradiog-
raphy.
Procedures for purification of the native and recombinant JHDM2A,
real-time PCR, and ChIP assays can be found in Supplemental Exper-
imental Procedures.
Supplemental Data
Supplemental Data include four figures and Supplemental Experimen-
tal Procedures and can be found with this article online at http://www.
cell.com/cgi/content/full/125/3/483/DC1/.
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